AstraZeneca in $560 m deal for respiratory firm
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Join the discussion below, or Read more at Seattle Times.
Since: Apr 13
#1 Jun 10, 2013
This sounds promising.
Add your comments below
|Just how bad is Yahoo's security breach? 'Equiv...||3 hr||just kiddeng||1|
|Vote For Donald Trump||10 hr||Go Blue Forever||17|
|Ron Fleishman is the World's Most Underrated Ph... (Sep '15)||17 hr||elvira||123|
|Review: Senior Helpers (Mar '16)||Sep 23||John A||3|
|Weird noises are coming Apple complex (Feb '16)||Sep 23||flbadcatowner||50|
|Sunnyvale Mugshots and Criminal Arrest Records||Sep 22||Carl||2|
|Report of Possible Alien Signal Sets SETI Commu...||Sep 19||Allright already||5|
Find what you want!
Search Palo Alto Forum Now
Copyright © 2016 Topix LLC